Skip to content
  • Thursday, February 25, 2021
  • Home
  • Unusual News

Healthcare Newsdesk

The Latest UK Healthcare News brought to you by NTSI

Banner Add
  • Home
  • Care Home News
  • Carers
  • Medicine & Clinical Practice
    • Arthritis
    • Blood & Stem Cell Donations
    • Brain Conditions
    • Cancer
    • Colds and Flu
    • Diabetes
    • Diet & Exercise
    • Downs Syndrome
    • Eyecare
    • Haemophilia
    • Intensive Care
    • Menopause
    • Mens Health
    • Mental Wellbeing
    • Psychology
    • Rare Medical Conditions
    • Sarcoidosis
    • Smoking
    • Women’s Health
  • Physiotherapy
  • Private Practice
  • Recruitment
  • Wellbeing at Work
  • Home
  • Clinical News
  • CNO regains lost status through key government advisory role
Clinical News

CNO regains lost status through key government advisory role

February 15, 2019
Nursing Times

[unable to retrieve full-text content]https://www.nursingtimes.net/news/policies-and-guidance/cno-regains-lost-status-through-key-government-advisory-role/7027883.article

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

Post navigation

Community provider wins decade-long deal for nursing services
Practice nurses called on to adopt standards for end of life care

RSS NHS Jobs – The Best of Both Worlds Northamptonshire

  • Group Chief Financial Officer

RSS GlobeNewswire RSS Feed

  • Autolus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
  • Admission to Trading on Euronext Brussels
  • Emergex Strengthens Senior Management Team
  • OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation
  • Silence Therapeutics to Participate in March Investor Conferences
  • Statement re Notice of Investor Presentation
  • Immunocore’s tebentafusp granted Breakthrough Therapy Designation for unresectable or metastatic uveal melanoma from FDA
  • Results of Placing – EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities
  • Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update on Early Positive Market Reception to US Launch of BARHEMSYS®
  • Mereo BioPharma to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference

See our other News Sites

  • News from Wales
  • Employer News
  • Camping In Britain
  • Wellbeing News
  • North Wales Business
  • UK Tech News
  • Healthcare Newsdesk
  • The UK Property Hub
  • Business in the News
  • UK Business News

Looking to target Healthcare Professionals?

Submit a Press Release

Copyright © 2021 Healthcare Newsdesk
Theme by: Theme Horse
Proudly Powered by: WordPress